Research Policies for Schizophrenia in the Global Health Context

References

• Glickman, S. W.; McHutchison, J. G.; Peterson, E. D.; Cairns, C. B.; Harrington R. A.; Califf R. M.; & Schulman, K. A. (2009) Ethical and scientific implications of the globalization of clinical research. New England Journal of Medicine, 360(8), 816-823.
   Google Scholar
• Van Dyke, C. (2011) Ethical perspectives: Clinical drug trials in developing countries. Oxford Handbook of Neuroethics (pp. 857-877). New York: Oxford University Press.
   Google Scholar
• Saxena, S.; Sharan, P.; Garrido, M.; & Saraceno, B. (2006) World Health Organization's Mental Health Atlas 2005: Implications for policy development. World Psychiatry, 5(3), 179-184.
   Google Scholar
• Prince, M.; Patel, V.; Saxena, S.; Maj, M.; Maselko, J.; Phillips, M. R.; & Rahman, A. (2007) No health without mental health. Lancet, 370(9590), 859-877.
   Google Scholar
• Lancet Global Mental Health Group; Chisholm, D.; Flisher, A. J.; Lund, C.; Patel, V.; Saxena, S.; Thornicroft, G.; & Tomlinson, M. (2007) Scale up services for mental disorders: A call for action. Lancet, 370(9594), 1241-1252.
   Google Scholar
• Saraceno, B.; van Ommeren, M.; Batniji, R.; Cohen, A.; Gureje, O.; Mahoney, J.; Sridhar, D.; & Underhill, C. (2007) Barriers to improvement of mental health services in low-income and middle-income countries. Lancet, 370(9593), 1164-1174.
   Google Scholar
• Saxena, S.; Thornicroft, G.; Knapp, M.; & Whiteford, H. (2007) Resources for mental health: Scarcity, inequity, and inefficiency. Lancet, 370(9590), 878-889.
   Google Scholar
• Mathers, C. D., & Loncar, D. (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine, 3(11), 2011-2030.
   Google Scholar
• Eaton, W. W.; Martins, S. S.; Nestadt, G.; Bienvenu, O. J.; Clarke, D.; & Alexandre, P. (2008) The burden of mental disorders. Epidemiologic Reviews, 30, 1-14.
   Google Scholar
• Narayan, K. M. V.; Ali, M. K.; del Rio, C.; Koplan, J. P.; & Curran, J. (2011) Global noncommunicable diseases—Lessons from the HIV-AIDS experience. New England Journal of Medicine, 365(10), 876-878.
   Google Scholar
• Beauchamp, T. L.; & Childress, J. F. (2008) Principles of Biomedical Ethics, 6th ed. New York: Oxford University Press.
   Google Scholar
• Takala, T. (2001) What is wrong with global bioethics? On the limitations of the four principles approach. Cambridge Quarterly Healthcare Ethics, 10(1), 72-77.
   Google Scholar
• Jing-Bao, N. (2005) Cultural values embodying universal norms: A critique of a popular assumption about cultures and human rights. Developing World Bioethics, 5(3), 251-257.
   Google Scholar
• Khushf, G. (2007) Importance of a midterm time horizon for addressing ethical issues integral to nanobiotechnology. Journal of Long-Term Effects of Medical Implants, 17(3), 263-269.
   Google Scholar
• Khushf, G. (2011) The ethics of nano/neuro convergence. Oxford Handbook of Neuroethics (pp. 467-492). New York: Oxford University Press.
   Google Scholar
• International HapMap Consortium. (2004) Integrating ethics and science in the International HapMap Project. Nature Reviews Genetics, 5(6), 467-475.
   Google Scholar
• Institute of Medicine. (2009) The U. S. commitment to global health: Recommen dations for the public and private sectors. Washington, D. C.: National Academies Press.
   Google Scholar
• Crisp, N. (2010) Turning the world upside down: The search for global health in the 21st century. London: The Royal Society of Medicine Press.
   Google Scholar
• Jablensky, A. (2000) Epidemiology of schizophrenia: The global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience, 250(6), 274-285.
   Google Scholar
• Saha, S.; Chant, D.; Welham, J.; & McGrath, J. (2005) A systematic review of the prevalence of schizophrenia. PLoS Medicine, 2(5), e141.
   Google Scholar
• Collins, P. Y.; Patel, V.; Joestl, S. S.; March, D.; Insel, T. R.; & Daar, A. S.;, Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health; Anderson, W.; Dhansay, M. A.; Phillips, A.; Shurin, S.; Walport, M.; Ewart, W.; Savill, S. J.; Bordin, I. A.; Costello, E. J.; Durkin, M.; Fairburn, C.; Glass, R. I.; Hall, W.; Huang, Y.; Hyman, S. E.; Jamison, K.; Kaaya, S.; Kapur, S.; Kleinman, A.; Ogunniyi, A.; Otero-Ojeda, A.; Poo, M. M.; Ravindranath, V.; Sahakian, B. J.; Saxena, S.; Singer, P. A.; & Stein, D. J. (2011) Grand challenges in global mental health. Nature, 475(7354), 27-30.
   Google Scholar
• World Health Organization. (1979) Schizophrenia: An international follow-up study. New York: John Wiley and Sons.
   Google Scholar
• Jablensky, A.; Sartorius, N.; Ernberg, G.; Anker, M.; Korten, A.; Cooper, J. E.; Day, R.; & Bertelsen, A. (1992) Schizophrenia: Manifestations, incidence and course in different cultures: A World Health Organization ten-country study. Psychological Medicine Monograph Supplement, 20, 1-97.
   Google Scholar
• Harrison, G.; Hopper, K.; Craig, T.; Laska, E.; Siegel, C.; Wanderling, J.; Dube, K. C.; Ganev, K.; Giel, R.; an der Heiden, W.; Holmberg, S. K.; Janca, A.; Lee, P. W.; León, C. A.; Malhotra, S.; Marsella, A. J.; Nakane, Y.; Sartorius, N.; Shen, Y.; Skoda, C.; Thara, R.; Tsirkin, S. J.; Varma, V. K.; Walsh, D.; & Wiersma, D. (2001) Recovery from psychotic illness: A 15- and 25-year international follow-up study. British Journal of Psychiatry, 178, 506-517.
   Google Scholar
• Hopper, K.; Harrison, G.; Janca, A.; & Sartorius, N. (Eds.) (2007) Recovery from schizophrenia: An international perspective. New York: Oxford University Press.
   Google Scholar
• Hopper, K., & Wanderling, J. (2000) Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: Results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia. Schizophrenia Bulletin, 26(4), 835-846.
   Google Scholar
• Chatterjee, S.; Patel, V.; Chatterjee, A.; & Weiss, H. A. (2003) Evaluation of a community-based rehabilitation model for chronic schizophrenia in rural India. British Journal of Psychiatry, 182, 57-62.
   Google Scholar
• New Freedom Commission on Mental Health: Final report. (2003) Washington, D. C.: SAMHSA. Available at <a target="_blank" href='http://www.mentalhealthcommission.gov/reports/reports.htm'>www.mentalhealthcommission.gov/reports/reports.htm</a>
   Google Scholar
• Chisholm, D. (2005) Choosing cost-effective interventions in psychiatry: Results from the CHOICE programme of the World Health Organization. World Psychiatry, 4(1), 37-44.
   Google Scholar
• International First Episode Vocational Recovery (iFEVR) Group. (2010) Meaningful lives: Supporting young people with psychosis in education, training and employment: An international consensus statement. Early Intervention in Psychiatry, 4(4), 323-326.
   Google Scholar
• Chatterjee, S.; Leese, M.; Koschorke, M.; McCrone, P.; Naik, S.; John, S.; Dabholkar, H.; Goldsmith, K.; Balaji, M.; Varghese, M.; Thara, R.; Patel, V.; Thornicroft, G.; & Community care for People with Schizophrenia in India (COPSI) group. (2011) Collaborative community based care for people and their families living with schizophrenia in India: Protocol for a randomized controlled trial. Trials, 12, 12.
   Google Scholar
• Cohen, A.; Patel, V.; Thara, R.; & Guruje, O. (2008) Questioning an axiom: Bet ter prognosis for schizophrenia in the developing world? Schizophrenia Bulletin, 34, 229-244.
   Google Scholar
• McGrath, J. (2008) Dissecting the heterogeneity of schizophrenia outcomes. Schizophrenia Bulletin, 34, 247-248.
   Google Scholar
• Leff, J. (2008) Comment on paper by Cohen, Patel, Thara, and Guruje. Schizophrenia Bulletin, 34, 251-252.
   Google Scholar
• Jablensky, A., & Sartorius, N. (2008) What did the WHO studies really find? Schizophrenia Bulletin, 34, 253-255.
   Google Scholar
• Bromet, E. J. (2008) Cross-national comparisons: Problems in interpretation when studies are based on prevalent cases. Schizophrenia Bulletin, 34, 256-257.
   Google Scholar
• Patel, V., & Sumathipala, A. (2001) International representation in psychiatric literature: Survey of six leading journals. British Journal of Psychiatry, 178, 406-409.
   Google Scholar
• Saraceno, B., & Saxena, S. (2004) Bridging the mental health research gap in low- and middle-income countries. Acta Psychiatrica Scandinavica, 110(1), 1-3.
   Google Scholar
• Saxena, S.; Maulik, P. K.; Sharan, P.; Levav, I.; & Saraceno, B. (2004) Brief report—Mental health research on low- and middle-income countries in indexed journals: A preliminary assessment. Journal of Mental Health Policy and Economics, 7(3), 127-131.
   Google Scholar
• Patel, V. (2007) Closing the 10/90 divide in global mental health research. Acta Psychiatrica Scandinavica, 115(4), 257-259.
   Google Scholar
• Hvistendahl, M. (2009) Demography. Making every baby girl count. Science, 323(5918), 1164-1166.
   Google Scholar
• Liberman, R. P., Kopelowicz, A.; Ventura, J.; & Gutkind, D. (2002) Operational criteria and factors related to recovery from schizophrenia. International Review of Psychiatry, 14, 256-272.
   Google Scholar
• Nasrallah, H. A.; Targum, S. D.; Tandon, R.; McCombs, J. S.; & Ross, R. (2005) Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatric Services, 56(3), 273-282.
   Google Scholar
• Ramon, S.; Healy, B.; & Renouf, N. (2007) Recovery from mental illness as an emergent concept and practice in Australia and the UK. International Journal of Social Psychiatry, 53(2), 108-122.
   Google Scholar
• Onken, S. J.; Craig, C. M.; Ridgway, P.; Ralph, R. O.; & Cook, J. A. (2007) An analysis of the definitions and elements of recovery: A review of the literature. Psychiatric Rehabilitation Journal, 31(1), 9-22.
   Google Scholar
• Silverstein, S. M., & Bellack, A. S. (2008) A scientific agenda for the concept of recovery as it applies to schizophrenia. Clinical Psychology Review, 28(7), 1108-1124.
   Google Scholar
• Warner, R. (2009) Recovery from schizophrenia and the recovery model. Current Opinion in Psychiatry, 22(4), 374-380.
   Google Scholar
• Romano, D. M.; McCay, E.; Goering, P.; Boydell, K.; & Zipursky, R. (2010) Reshaping an enduring sense of self: The process of recovery from a first episode of schizophrenia. Early Intervention in Psychiatry, 4(3), 243-250.
   Google Scholar
• Chiu, M. Y.; Ho, W. W.; Lo, W. T.; Yiu, M. G. (2010) Operationalization of the SAMHSA model of recovery: A quality of life perspective. Quality of Life Research, 19(1), 1-13.
   Google Scholar
• Liberman, R. P., & Kopelowicz, A. (2005) Recovery from schizophrenia: A concept in search of research. Psychiatric Services, 56, 735-742.
   Google Scholar
• Lieberman, J. A.; Drake, R. E.; Sederer, L. I.; Belger, A.; Keefe, R.; Perkins, D.; & Stroup, S. (2008) Science and recovery in schizophrenia. Psychiatric Services, 59(5), 487-496.
   Google Scholar
• Brabban, A.; Tai, S.; & Turkington, D. (2009) Predictors of outcome in brief cognitive behavior therapy for schizophrenia. Schizophrenia Bulletin, 35(5), 859-864.
   Google Scholar
• Bush, P. W.; Drake, R. E.; Xie, H.; McHugo, G. J.; & Haslett, W. R. (2009) The long-term impact of employment on mental health service use and costs for persons with severe mental illness. Psychiatric Services, 60(8), 1024-1031.
   Google Scholar
• Barton, G. R.; Hodgekins, J.; Mugford, M.; Jones, P. B.; Croudace, T.; & Fowler, D. (2009) Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis. Schizophrenia Research, 112(1-3), 158-163.
   Google Scholar
• Pharoah, F.; Mari, J.; Rathbone, J.; & Wong, W. (2010) Family intervention for schizophrenia. Cochrane Database of Systematic Reviews, 8(12), CD000088.
   Google Scholar
• Tandon, R.; Nasrallah, H. A.; & Keshavan, M. S. (2010) Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophrenia Research, 122(1-3), 1-23.
   Google Scholar
• Patel, A.; Knapp, M.; Romeo, R.; Reeder, C.; Matthiasson, P.; Everitt, B.; & Wykes, T. (2010) Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis. Schizophrenia Research, 120(1-3), 217-224.
   Google Scholar
• Mead, S., & Copeland, M. E. (2000) What recovery means to us: Consumers' perspectives. Community Mental Health Journal, 36(3), 315-328.
   Google Scholar
• Myers, N. L. (2010) Culture, stress and recovery from schizophrenia: Lessons from the field for global mental health. Culture, Medicine and Psychiatry, 34(3), 500-528.
   Google Scholar
• Palmer, B. A.; Pankratz, V. S.; & Bostwick, J. M. (2005) The lifetime risk of suicide in schizophrenia: A reexamination. Archives of General Psychiatry, 62(3), 247-253.
   Google Scholar
• Patel, V.; Cohen, A.; Thara, R.; & Gureje, O. (2006) Is the outcome of schizophrenia really better in developing countries? Revista Brasileira de Psiquiatria, 28(2), 149-152.
   Google Scholar
• Saha, S.; Chant, D.; & McGrath, J. (2007) A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time? Archives of General Psychiatry, 64(10), 1123-1131.
   Google Scholar
• Elias, M. (2007, May 3) Mentally ill die 25 years earlier, on average. USA Today. Available at <a target="_blank" href='http://www.usatoday.com/news/health/2007-05-03-mental-illness_N.htm'>www.usatoday.com/news/health/2007-05-03-mental-illness_N.htm</a>
   Google Scholar
• Parks, J.; Swendsen, D.; Singer, P.; & Foti, M. (Eds.) (2008) Morbidity and mortality in people with serious mental illness: National Association of State Mental Health Program Directors, Medical Directors Council. Available at <a target="_blank" href='http://www.nasmhpd.org/general_files/publications/med_directors_pubs/Mortality_and_Morbidity_Final_Report_8.18.08.pdf'>www.nasmhpd.org/general_files/publications/med_directors_pubs/Mortality_and_Morbidity_Final_Report_8.18.08.pdf</a>
   Google Scholar
• Tiihonen, J.; Lönnqvist, J.; Wahlbeck, K.; Klaukka, T.; Niskanen, L.; Tanskanen, A.; & Haukka, J. (2009) 11-year follow-up of mortality in patients with schizophrenia: A population-based cohort study (FIN11 study). Lancet, 374(9690), 620-627.
   Google Scholar
• Chwastiak, L. A., & Tek, C. (2009) The unchanging mortality gap for people with schizophrenia. Lancet, 374(9690), 590-592.
   Google Scholar
• Naqvi, H. A.; Hussain, S.; Zaman, M.; & Islam, M. (2009) Pathways to care: Duration of untreated psychosis from Karachi, Pakistan. PLoS One, 4(10), e7409.
   Google Scholar
• Wang, P. S.; Ulbricht, C. M.; & Schoenbaum, M. (2009) Improving mental health treatments through comparative effectiveness research. Health Affairs, 28(3), 783-791.
   Google Scholar
• Susser, E.; Neugebauer, R.; Hoek, H. W.; Brown, A. S.; Lin, S.; Labovitz, D.; & Gorman, J. M. (1996) Schizophrenia after prenatal famine. Further evidence. Archives of General Psychiatry, 53(1), 25-31.
   Google Scholar
• van Os, J. (1997) Schizophrenia after prenatal famine. Archives of General Psychiatry, 54(6), 577-578.
   Google Scholar
• St. Clair, D.; Xu, M.; Wang, P.; Yu, Y.; Fang, Y.; Zhang, F.; Zheng, X.; Gu, N.; Feng, G.; Sham, P.; & He, L. (2005) Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. Journal of the American Medical Association, 294(5), 557-562.
   Google Scholar
• Song, S.; Wang, W.; & Hu, P. (2009) Famine, death, and madness: Schizophrenia in early adulthood after prenatal exposure to the Chinese Great Leap Forward famine. Social Science & Medicine, 68(7), 1315-1321.
   Google Scholar
• Xu, M. Q.; Sun, W. S.; Liu, B. X.; Feng, G. Y.; Yu, L.; Yang, L.; He, G.; Sham, P.; Susser, E.; St. Clair, D.; & He, L. (2009) Prenatal malnutrition and adult schizophrenia: Further evidence from the 1959-1961 Chinese famine. Schizophrenia Bulletin, 35(3), 568-576.
   Google Scholar
• Pearce, B. D. (2001) Schizophrenia and viral infection during neurodevelopment: A focus on mechanisms. Molecular Psychiatry, 6(6), 634-646.
   Google Scholar
• United Nations. (2008) The Millennium Development Goals Report. New York: United Nations Publications. Available at <a target="_blank" href='http://www.un.org/millenniumgoals/2008highlevel/pdf/newsroom/mdg%20reports/MDG_Report_2008_ENGLISH.pdf'>www.un.org/millenniumgoals/2008highlevel/pdf/newsroom/mdg%20reports/MDG_Report_2008_ENGLISH.pdf</a>
   Google Scholar
• GAVI Alliance. Available at <a target="_blank" href='http://www.gavialliance.org'>www.gavialliance.org</a>
   Google Scholar
• Hickman, M.; Vickerman, P.; Macleod, J.; Kirkbride, J.; & Jones, P. B. (2007) Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction, 102, 597-606.
   Google Scholar
• van Os, J.; Bak, M.; Hanssen, M.; Bijl, R. V.; de Graaf, R.; & Verdoux, H. (2002) Cannabis use and psychosis: A longitudinal population-based study. American Journal of Epidemiology, 156, 319-327.
   Google Scholar
• Arseneault, L.; Cannon, M.; Poulton, R.; Murray, R.; Caspi, A.; & Moffitt, T. E. (2002) Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal, 325, 1212-1213.
   Google Scholar
• Fergusson, D. M.; Horwood, L. J.; & Swain-Campbell, N. R. (2003) Cannabis dependence and psychotic symptoms in young people. Psychological Medicine, 33, 15-21.
   Google Scholar
• Henquet, C.; Krabbendam, L.; Spauwen, J.; Kaplan, C.; Lieb, R.; Wittchen, H. U.; & van Os, J. (2005) Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. British Medical Journal, 330, 11.
   Google Scholar
• Andréasson, S.; Allebeck, P.; Engström, A.; & Rydberg, U. (1987) Cannabis and schizophrenia: A longitudinal study of Swedish conscripts. Lancet, 330, 1483-1486.
   Google Scholar
• Hall, W. (2006) Is cannabis use psychotogenetic? Lancet, 367, 193-195.
   Google Scholar
• Turner, W. M., & Tsuang, M. T. (1990) Impact of substance abuse on the course and outcome of schizophrenia. Schizophrenia Bulletin, 16(1), 87-95.
   Google Scholar
• Negrete, J. C.; Knapp, W. P.; Douglas, D. E.; & Smith, W. B. (1986) Cannabis affects the severity of schizophrenic symptoms: Results of a clinical survey. Psychological Medicine, 16(3), 515-520.
   Google Scholar
• Linszen, D., & van Amelsvoort, T. (2007) Cannabis and psychosis: An update on course and biological plausible mechanisms. Current Opinion in Psychiatry, 20(2), 116-120.
   Google Scholar
• Thornicroft, G. (1990) Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry, 157, 25-33.
   Google Scholar
• Hall, W., & Solowij, N. (1998) Adverse effects of cannabis. Lancet, 352(9140), 1611-1616.
   Google Scholar
• Degenhardt, L.; Hall, W.; & Lynskey, M. (2003) Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71(1), 37-48.
   Google Scholar
• Sewell, R. A.; Skosnik, P. D.; Garcia-Sosa, I.; Ranganathan, M.; & D'Souza, D. C. (2010) Behavioral, cognitive and psychophysiological effects of cannabinoids: Relevance to psychosis and schizophrenia. Revista Brasileira de Psiquiatria, 32(Supplement 1), S15-S30.
   Google Scholar
• Hoffman, R., & Davidson, L. (1999) Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly, 70, 273-287.
   Google Scholar
• Yung, A. R.; McGorry, P. D.; McFarlane, C. A.; Jackson, H. J.; Patton, G. C.; & Rakkar, A. (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22, 283-303.
   Google Scholar
• Klosterkötter, J.; Hellmich, M.; Steinmeyer, E. M.; & Schultze-Lutter, F. (2001) Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158-164.
   Google Scholar
• Wyatt, R. J., & Henter, I. (2001) Rationale for the study of early intervention. Schizophrenia Research, 51(1), 69-76.
   Google Scholar
• Farooq, S.; Large, M.; Nielssen, O.; & Waheed, W. (2009) The relationship between the duration of untreated psychosis and outcome in low- and middle-income countries: A systematic review and meta analysis. Schizophrenia Research, 109(1-3), 15-23.
   Google Scholar
• Coentre, R.; Levy, P.; & Figueira, M. L. (2010) Early intervention in psychosis: Prepsychotic period. Acta Médica Portuguesa, 23(6), 1083-1090.
   Google Scholar
• Marshall, M., & Rathbone, J. (2011) Early intervention for psychosis. Schizophrenia Bulletin, 37(6), 1111-1114.
   Google Scholar
• McGlashan, T. H. (2001) Psychosis treatment prior to psychosis onset: Ethical issues. Schizophrenia Research, 51(1), 47-54.
   Google Scholar
• DeGrazia, D. (2001) Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia. Schizophrenia Research, 51(1), 77-86.
   Google Scholar
• van Leeuwen, E. (2001) Dutch law and ethics concerning the experimental treatment of early psychosis. Schizophrenia Research, 51(1), 63-67.
   Google Scholar
• Schaffner, K. F., & McGorry, P. D. (2001) Preventing severe mental illnesses—New prospects and ethical challenges. Schizophrenia Research, 51(1), 3-15.
   Google Scholar
• Francey, S. M.; Nelson, B.; Thompson, A.; Parker, A. G.; Kerr, M.; Macneil, C.; Fraser, R.; Hughes, F.; Crisp, K.; Harrigan, S.; Wood, S. J.; Berk, M.; & McGorry, P. D. (2010) Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophrenia Research, 119(1-3), 1-10.
   Google Scholar
• Amminger, G. P.; Schäfer, M. R.; Papageorgiou, K.; Klier, C. M.; Cotton, S. M.; Harrigan, S. M.; Mackinnon, A.; McGorry, P. D.; & Berger, G. E. (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: A randomized, placebo-controlled trial. Archives of General Psychiatry, 67(2), 146-154.
   Google Scholar
• Yung, A. R.; Phillips, L. J.; Nelson, B.; Francey, S. M.; Yuen, H. P.; Simmons, M. B.; Ross, M. L.; Kelly, D.; Dip, G.; Baker, K.; Amminger, G. P.; Berger, G.; Thompson, A. D.; Thampi, A.; & McGorry, P. D. (2011) Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. Journal of Clinical Psychiatry, 72(4), 430-440.
   Google Scholar
• Kohn, R.; Saxena, S.; Levav, I.; & Saraceno, B. (2004) The treatment gap in mental health care. Bulletin of the World Health Organization, 82(11), 858-866.
   Google Scholar
• World Health Organization. (2001) The world health report 2001, Mental health: New understanding, new hope. Geneva.
   Google Scholar
• Jacob, K. S.; Sharan, P.; Mirza, I.; Garrido-Cumbrera, M.; Seedat, S.; Mari, J. J.; Sreenivas, V.; & Saxena, S. (2007) Mental health systems in countries: Where are we now? Lancet, 370(9592), 1061-1077.
   Google Scholar
• World Health Organization. (2008) mhGAP: mental health action programme: Scaling up care for mental neurological, and substance use disorders. Geneva.
   Google Scholar
• Bruckner, T. A.; Scheffler, R. M.; Shen, G.; Yoon, J.; Chisholm, D.; Morris, J.; Fulton, B. D.; Dal Poz, M. R.; & Saxena, S. (2011) The mental health workforce gap in low- and middle-income countries: A needs-based approach. Bulletin of the World Health Organization, 89(3), 184-194.
   Google Scholar
• Wiley-Exley, E. (2007) Evaluations of community mental health care in low- and middle-income countries: A 10-year review of the literature. Social Science & Medicine, 64(6), 1231-1241.
   Google Scholar
• Botha, U. A.; Koen, L.; Joska, J. A.; Hering, L. M.; & Oosthuizen, P. P. (2010) Assessing the efficacy of a modified assertive community-based treatment programme in a developing country. BMC Psychiatry, 10, 73.
   Google Scholar
• Murthy, R. S.; Kishore Kumar, K. V.; Chisholm, D.; Thomas, T.; Sekar, K.; & Chandrashekar, C. R. (2005) Community outreach for untreated schizophrenia in rural India: A follow-up study of symptoms, disability, family burden and costs. Psychological Medicine, 35, 341-351.
   Google Scholar
• Yamey, G. (2011) Scaling up global health interventions: A proposed framework for success. PLoS Medicine, 8(6), e1001049.
   Google Scholar
• Lehman, A. F., & Steinwachs, D. M. (1998) Patterns of usual care for schizophrenia: Initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. Schizophrenia Bulletin, 24(1), 11-20; discussion 20-32.
   Google Scholar
• Lehman, A. F.; Kreyenbuhl, J.; Buchanan, R. W.; Dickerson, F. B.; Dixon, L. B.; Goldberg, R.; Green-Paden, L. D.; Tenhula, W. N.; Boerescu, D.; Tek, C.; Sandson, N.; & Steinwachs, D. M. (2004) The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophrenia Bulletin, 30(2), 193-217.
   Google Scholar
• Drake, R.; Skinner, J.; & Goldman, H. H. (2008) What explains the diffusion of treatments for mental illness? American Journal of Psychiatry, 165(11), 1385-1392.
   Google Scholar
• Sederer, L. I. (2009) Changing the oil while driving the car. Psychiatric Services, 60(5), 575.
   Google Scholar
• Drake, R. E., & Essock, S. M. (2009) The science-to-service gap in real-world schizophrenia treatment: The 95% problem. Schizophrenia Bulletin, 35(4), 677-678.
   Google Scholar
• Mojtabai, R.; Fochtmann, L.; Chang, S. W.; Kotov, R.; Craig, T. J.; & Bromet, E. (2009) Unmet need for mental health care in schizophrenia: An overview of literature and new data from a first-admission study. Schizophrenia Bulletin, 35(4), 679-695.
   Google Scholar
• Marcus, S. C., & Olfson, M. (2008) Outpatient antipsychotic treatment and inpatient costs of schizophrenia. Schizophrenia Bulletin, 34(1), 173-180.
   Google Scholar
• Lehman, A. F. (2009) Leaping tall buildings—The science-to-service gap in schizophrenia treatment. Schizophrenia Bulletin, 35(4), 659-660.
   Google Scholar
• Horvitz-Lennon, M.; Donohue, J. M.; Domino, M. E.; & Normand, S. L. (2009) Improving quality and diffusing best practices: The case of schizophrenia. Health Affairs, 28(3), 701-712.
   Google Scholar
• Sederer, L. I. (2009) Science to practice: Making what we know what we actually do. Schizophrenia Bulletin, 35(4), 714-718.
   Google Scholar
• Hogan, M. (2010) Updated schizophrenia PORT treatment recommendations: A commentary. Schizophrenia Bulletin, 36(1), 104-106.
   Google Scholar
• Pincus, H. A. (2010) From PORT to policy to patient outcomes: Crossing the quality chasm. Schizophrenia Bulletin, 36(1), 109-111.
   Google Scholar
• Depp, C., & Lebowitz, B. D. (2007) Clinical trials: Bridging the gap between efficacy and effectiveness. International Review of Psychiatry, 19(5), 531-539.
   Google Scholar
• International Schizophrenia Consortium; Purcell, S. M.; Wray, N. R.; Stone, J. L.; Visscher, P. M.; O'Donovan, M. C.; Sullivan, P. F.; & Sklar, P. (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748-752.
   Google Scholar
• The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Con sortium (2011) Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969-976.
   Google Scholar
• Chokshi, D. A.; Parker, M.; & Kwiatkowski, D. P. (2006) Data sharing and intellectual property in a genomic epidemiology network: Policies for large-scale research collaboration. Bulletin of the World Health Organization, 84(5), 382-387.
   Google Scholar
• Nyika, A. (2009) Ethical and practical challenges surrounding genetic and genomic research in developing countries. Acta Tropica, 112 (Supplement 1), S21-S31.
   Google Scholar
• Chokshi, D. A.; Thera, M. A.; Parker, M.; Diakite, M.; Makani, J.; Kwiatkowski, D. P.; & Doumbo, O. K. (2007) Valid consent for genomic epidemiology in developing countries. PLoS Medicine, 4(4), e95.
   Google Scholar
• Sullivan, P. F. (2010) The psychiatric GWAS consortium: Big science comes to psychiatry. Neuron, 68(2), 182-186.
   Google Scholar
• Holmes, E.; Tsang, T. M.; Huang, J. T.; Leweke, F. M.; Koethe, D.; Gerth, C. W.; Nolden, B. M.; Gross, S.; Schreiber, D.; Nicholson, J. K.; & Bahn, S. (2006) Metabolic profiling of CSF: Evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Medicine, 3(8), e327.
   Google Scholar
• Schwarz, E.; Izmailov, R.; Spain, M.; Barnes, A.; Mapes, J. P.; Guest, P. C.; Rahmoune, H.; Pietsch, S.; Leweke, F. M.; Rothermundt, M.; Steiner, J.; Koethe, D.; Kranaster, L.; Ohrmann, P.; Suslow, T.; Levin, Y.; Bogerts, B.; van Beveren, N. J.; McAllister, G.; Weber, N.; Niebuhr, D.; Cowan, D.; Yolken, R. H.; & Bahn, S. (2010) Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomark Insights, 5, 39-47.
   Google Scholar
• Schwarz, E.; Guest, P. C.; Rahmoune, H.; Harris, L. W.; Wang, L.; Leweke, F. M.; Rothermundt, M.; Bogerts, B.; Koethe, D.; Kranaster, L.; Ohrmann, P.; Suslow, T.; McAllister, G.; Spain, M.; Barnes, A.; van Beveren, N. J.; Baron-Cohen, S.; Steiner, J.; Torrey, F. E.; Yolken, R. H.; & Bahn, S. (2011, April 12) Identification of a biological signature for schizophrenia in serum. Molecular Psychiatry. Available at <a target="_blank" href='http://www.nature.com/mp/journal/vaop/ncurrent/pdf/mp201142a.pdf'>www.nature.com/mp/journal/vaop/ncurrent/pdf/mp201142a.pdf</a>
   Google Scholar
• Royal College of Pathologists (2006) Evaluating and introducing new diagnostic tests: The need for a national strategy. Available at <a target="_blank" href='http://www.rcpath.org/resources/pdf/Evaluating_and_introducing_new_diagnostic_tests.pdf'>www.rcpath.org/resources/pdf/Evaluating_and_introducing_new_diagnostic_tests.pdf</a>
   Google Scholar
• Thompson, B. M., & Kendall, L. R. (2009) The case for regulating laboratorydeveloped tests. IVD Technology. Available at <a target="_blank" href='http://www.ivdtechnology.com/article/caseregulating-laboratory-developed-tests'>www.ivdtechnology.com/article/caseregulating-laboratory-developed-tests</a>
   Google Scholar
• Institute of Medicine. (2011) Medical devices and the public's health: The FDA 510(k) clearance and process at 35 years. Washington, D. C.: National Academies Press.
   Google Scholar
• Gibbs, J. N. (2011) Regulating molecular diagnostic assays: Developing a new regulatory structure for a new technology. Expert Review of Molecular Diagnostics, 11(4), 367-381.
   Google Scholar
• Lieberman, J. A.; Stroup, T. S.; McEvoy, J. P.; Swartz, M. S.; Rosenheck, R. A.; Perkins, D. O.; Keefe, R. S.; Davis, S. M.; Davis, C. E.; Lebowitz, B. D.; Severe, J.; Hsiao, J. K.; & Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353(12), 1209-1023.
   Google Scholar
• Stroup, T. S.; Lieberman, J. A.; McEvoy, J. P.; Swartz, M. S.; Davis, S. M.; Rosenheck, R. A.; Perkins, D. O.; Keefe, R. S.; Davis, C. E.; Severe, J.; Hsiao, J. K.; & CATIE Investigators. (2006) Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. American Journal of Psychiatry, 163(4), 611-622.
   Google Scholar
• McEvoy, J. P.; Lieberman, J. A.; Stroup, T. S.; Davis, S. M.; Meltzer, H. Y.; Rosenheck, R. A.; Swartz, M. S.; Perkins, D. O.; Keefe, R. S.; Davis, C. E.; Severe, J.; Hsiao, J. K.; & CATIE Investigators. (2006) Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. American Journal of Psychiatry, 163(4), 600-610.
   Google Scholar
• Rosenheck, R. A.; Leslie, D. L.; Sindelar, J.; Miller, E. A.; Lin, H.; Stroup, T. S.; McEvoy, J.; Davis, S. M.; Keefe, R. S.; Swartz, M.; Perkins, D. O.; Hsiao, J. K.; Lieberman, J; & CATIE Study Investigators. (2006) Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. American Journal of Psychiatry, 163(12), 2080-2089.
   Google Scholar
• Chen, L.; McCombs, J. S.; & Park, J. (2008) Duration of antipsychotic drug therapy in real-world practice: A comparison with CATIE trial results. Value Health, 11(3), 487-496.
   Google Scholar
• Kreyenbuhl, J.; Slade, E. P.; Medoff, D. R.; Brown, C. H.; Ehrenreich, B.; Afful, J.; & Dixon, L. B. (2011) Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia. Schizophrenia Research, 131(1-3), 127-132.
   Google Scholar
• Rosenheck, R. A. (2006) Outcomes, costs, and policy caution. A commentary on the cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1) Archives of General Psychiatry, 63(10), 1074-1076.
   Google Scholar
• Frank, R. G. (2008) Policy toward second-generation antipsychotic drugs: A cautionary note. Psychiatric Services, 59(5), 521-522.
   Google Scholar
• Duckworth, K., & Fitzpatrick, M. J. (2008) NAMI perspective on CATIE: Policy and research implications. Psychiatric Services, 59(5), 537-539.
   Google Scholar
• Domino, M. E., & Swartz, M. S. (2008) Who are the new users of antipsychotic medications? Psychiatric Services, 59(5), 507-514.
   Google Scholar
• Covell, N. H.; Finnerty, M. T.; & Essock, S. M. (2008) Implications of CATIE for mental health services researchers. Psychiatric Services, 59(5), 526-529.
   Google Scholar
• Tandon, R.; Belmaker, R. H.; Gattaz, W. F.; Lopez-Ibor, J. J., Jr.; Okasha, A.; Singh, B.; Stein, D. J.; Olie, J. P.; Fleischhacker, W. W.; Moeller, H. J.; & Section of Pharmacopsychiatry, World Psychiatric Association. (2008) World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophrenia Research, 100(1-3), 20-38.
   Google Scholar
• Swartz, M. S. (2008) Introduction to the CATIE special section. Psychiatric Services, 59(5), 497-499.
   Google Scholar
• Rosenheck, R. A.; Leslie, D. L.; & Doshi, J. A. (2008) Second-generation antipsychotics: Cost-effectiveness, policy options, and political decision making. Psychiatric Services, 59(5), 515-520.
   Google Scholar
• Kraemer, H. C.; Glick, I. D.; & Klein, D. F. (2009) Clinical trials design lessons from the CATIE study. American Journal of Psychiatry, 166(11), 1222-1228.
   Google Scholar
• Rosenheck, R. A., & Sernyak, M. J. (2009) Developing a policy for second-generation antipsychotic drugs. Health Affairs, 28(5), w782-w793.
   Google Scholar
• Parks, J. J.; Radke, A. Q.; & Tandon, R. (2008) Impact of the CATIE findings on state mental health policy. Psychiatric Services, 59(5), 534-536.
   Google Scholar
• Lavedan, C.; Licamele, L.; Volpi, S.; Hamilton, J.; Heaton, C.; Mack, K.; Lannan, R.; Thompson, A.; Wolfgang, C. D.; & Polymeropoulos, M. H. (2009) Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. Molecular Psychiatry, 14(8), 804-819.
   Google Scholar
• Scott, L. J. (2009) Iloperidone: In schizophrenia. CNS Drugs, 23(10), 867-880.
   Google Scholar
• FDA (2011, July 14) Draft guidance for industry and food and drug administration staff—In vitro companion diagnostic devices. Available at <a target="_blank" href='http://www.bcg-usa.com/regulatory/docs/2011/FDA20117D.pdf'>www.bcg-usa.com/regulatory/docs/2011/FDA20117D.pdf</a>
   Google Scholar
• National Advisory Mental Health Council's Workgroup. (2010) From discovery to cure: Accelerating the development of new and personalized interventions for mental illnesses. Report of the National Advisory Mental Health Council's Workgroup. Available at <a target="_blank" href='http://www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/reports/fromdis-coverytocure.pdf'>www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/reports/fromdis-coverytocure.pdf</a>
   Google Scholar
• Owen, M. J.; Craddock, N.; & Jablensky, A. (2007) The genetic deconstruction of psychosis. Schizophrenia Bulletin, 33(4), 905-911.
   Google Scholar
• Rothbard, A. B.; Kuno, E.; & Foley, K. (2003) Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia. Schizophrenia Bulletin, 29(3), 531-540.
   Google Scholar
• Leslie, D. L., & Rosenheck, R. A. (2002) From conventional to atypical antipsychotics and back: Dynamic processes in the diffusion of new medications. American Journal of Psychiatry, 159(9), 1534-1540.
   Google Scholar
• Weissman, E. M. (2002) Antipsychotic prescribing practices in the Veterans Healthcare Administration—New York metropolitan region. Schizophrenia Bulletin, 28(1), 31-42.
   Google Scholar
• Essock, S. M.; Frisman, L. K.; Covell, N. H.; & Hargreaves, W. A. (2000) Cost-effectiveness of clozapine compared with conventional antipsychotic medication for patients in state hospitals. Archives of General Psychiatry, 57(10), 987-994.
   Google Scholar
• Kane, J.; Honigfeld, G.; Singer, J.; & Meltzer, H. (1988) Clozapine for the treatment- resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45(9), 789-796.
   Google Scholar
• Pickar, D.; Owen, R. R.; Litman, R. E.; Konicki, E.; Gutierrez, R.; & Rapaport, M. H. (1992) Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Archives of General Psychiatry, 49(5), 345-353.
   Google Scholar
• Volavka, J.; Czobor, P.; Sheitman, B.; Lindenmayer, J. P.; Citrome, L.; McEvoy, J. P.; Cooper, T. B.; Chakos, M.; & Lieberman, J. A. (2002) Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder. American Journal of Psychiatry, 159(2), 255-262.
   Google Scholar
• Brunette, M. F.; Drake, R. E.; Xie, H.; McHugo, G. J.; & Green, A. I. (2006) Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin, 32(4), 637-643.
   Google Scholar
• Meltzer, H. Y.; Cola, P.; Way, L.; Thompson, P. A.; Bastani, B.; Davies, M. A.; & Snitz, B. (1993) Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia. American Journal of Psychiatry, 150(11), 1630-1638.
   Google Scholar
• Rosenheck, R.; Cramer, J.; Xu, W.; Thomas, J.; Henderson, W.; Frisman, L.; Fye, C.; & Charney, D. (1997) A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. New England Journal of Medicine, 337(12), 809-815.
   Google Scholar
• Lewis, S. W.; Barnes, T. R.; Davies, L.; Murray, R. M.; Dunn, G.; Hayhurst, K. P.; Markwick, A.; Lloyd, H.; & Jones, P. B. (2006) Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia Bulletin, 32(4), 715-723.
   Google Scholar
• Honigfeld, G.; Arellano, F.; Sethi, J.; Bianchini, A.; & Schein, J. (1998) Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. Journal of Clinical Psychiatry, 59(Supplement 3), 3-7.
   Google Scholar
• Dettling, M.; Cascorbi, I.; Opgen-Rhein, C.; & Schaub, R. (2007) Clozapine-induced agranulocytosis in schizophrenic Caucasians: Confirming clues for associations with human leukocyte class I and II antigens. Pharmacogenomics Journal, 7(5), 325-332.
   Google Scholar
• Athanasiou, M. C.; Dettling, M.; Cascorbi, I.; Mosyagin, I.; Salisbury, B. A.; Pierz, K. A.; Zou, W.; Whalen, H.; Malhotra, A. K.; Lencz, T.; Gerson, S. L.; Kane, J. M.; & Reed, C. R. (2011) Candidate gene analysis identifies a polymorphism in HLA-DQB1 associated with clozapine-induced agranulocytosis. Journal of Clinical Psychiatry, 72(4), 458-463.
   Google Scholar
• Chen, P.; Lin, J. J.; Lu, C. S.; Ong, C. T.; Hsieh, P. F.; Yang, C. C.; Tai, C. T.; Wu, S. L.; Lu, C. H.; Hsu, Y. C.; Yu, H. Y.; Ro, L. S.; Lu, C. T.; Chu, C. C.; Tsai, J. J.; Su, Y. H.; Lan, S. H.; Sung, S. F.; Lin, S. Y.; Chuang, H. P.; Huang, L. C.; Chen, Y. J.; Tsai, P. J.; Liao, H. T.; Lin, Y. H.; Chen, C. H.; Chung, W. H.; Hung, S. I.; Wu, J. Y.; Chang, C. F.; Chen, L.; Chen, Y. T.; Shen, C. Y.; & Taiwan SJS Consortium. (2011) Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. New England Journal of Medicine, 364(12), 1126-1133.
   Google Scholar
• Sartorius, N. (2007) Stigma and mental health. Lancet, 370(9590), 810-811.
   Google Scholar
• Dhanda, A., & Narayan, T. (2007) Mental health and human rights. Lancet, 370(9594), 1197-1198.
   Google Scholar
• Pincus, F. L. (1996) Discrimination comes in many forms—individual, institutional, and structural. American Behavioral Scientist, 40, 186-194.
   Google Scholar
• Thornicroft, G.; Brohan, E.; Rose, D.; Sartorius, N.; Leese, M.; & INDIGO Study Group (2009) Global pattern of experienced and anticipated discrimination against people with schizophrenia: A cross-sectional survey. Lancet, 373(9661), 408-415.
   Google Scholar
• Lee, S.; Chiu, M. Y.; Tsang, A.; Chui, H.; & Kleinman, A. (2006) Stigmatizing experience and structural discrimination associated with the treatment of schizophrenia in Hong Kong. Social Science & Medicine, 62(7), 1685-1696.
   Google Scholar
• Katontoka, S. (2007) Users' networks for Africans with mental disorders. Lancet, 370(9591), 919-920.
   Google Scholar
• Sartorius, N. (2002) Iatrogenic stigma of mental illness. British Medical Journal, 324(7352), 1470-1471.
   Google Scholar
• World Health Organization. (2006) The world health report 2006—Working together for health. Available at <a target="_blank" href='http://www.who.int/whr/2006/en/index.html'>www.who.int/whr/2006/en/index.html</a>
   Google Scholar
• Ghebrehiwet, T., & Barrett, T. (2007) Nurses and mental health services in developing countries. Lancet, 370(9592), 1016-1017.
   Google Scholar
• Frenk, J.; Chen, L.; Bhutta, Z. A.; Cohen, J.; Crisp, N.; Evans, T.; Fineberg, H.; Garcia, P.; Ke, Y.; Kelley, P.; Kistnasamy, B.; Meleis, A.; Naylor, D.; Pablos-Mendez, A.; Reddy, S.; Scrimshaw, S.; Sepulveda, J.; Serwadda, D.; & Zurayk, H. (2010) Health professionals for a new century: Transforming education to strengthen health systems in an interdependent world. Lancet, 376(9756), 1923-1958.
   Google Scholar
• Treadway, K., & Chatterjee, N. (2011) Into the water—The clinical clerkships. New England Journal of Medicine, 364(13), 1190-1193.
   Google Scholar
• Lester, H.; Tritter, J. Q.; & England, E. (2003) Satisfaction with primary care: the perspectives of people with schizophrenia. Family Practice, 20(5), 508-513.
   Google Scholar
• World Health Organization. (2004) Galvanizing mental health research in lowand middle-income countries: Role of scientific journals. Acta Psychiatrica Scandinavica, 110(1), 77-79.
   Google Scholar
• Razzouk, D.; Sharan, P.; Gallo, C.; Gureje, O.; Lamberte, E. E.; de Jesus Mari, J.; Mazzotti, G.; Patel, V.; Swartz, L.; Olifson, S.; Levav, I.; de Francisco, A.; Saxena, S.; & WHO-Global Forum for Health Research Mental Health Research Mapping Project Group. (2010) Scarcity and inequity of mental health research resources in low-and-middle income countries: A global survey. Health Policy, 94(3), 211-220.
   Google Scholar
• Saxena, S.; Sharan, P.; & Saraceno, B. (2004) Research for change: The role of scientific journals publishing mental health research. World Psychiatry, 3(2), 66-72.
   Google Scholar
• de Jesus Mari, J.; Patel, V.; Kieling, C.; Anders, M.; Jakovljevi, M.; Lam, L. C.; Lotaief, F.; Mendlowicz, M. V.; Okulat, G.; Sathyanarayana Rao, T. S.; Tamam, L.; Tyrer, P.; & Herrman, H. (2009) The 5/95 Gap on the dissemination of mental health research: The World Psychiatric Association (WPA) task force report on project with editors of low- and middle-income (LAMI) countries. African Journal of Psychiatry, 12(1), 33-39.
   Google Scholar
• Teo, A. R. (2009) The development of clinical research training: Past history and current trends in the United States. Academic Medicine, 84(4), 433-438.
   Google Scholar
• Goldhamer, M. E.; Cohen, A. P.; Bates, D. W.; Cook, E. F.; Davis, R. B.; Singer, D. E.; & Simon, S. R. (2009) Protecting an endangered species: Training physicians to conduct clinical research. Academic Medicine, 84(4), 439-445.
   Google Scholar
• Zumla, A.; Huggett, J.; Dheda, K.; Green, C.; Kapata, N.; & Mwaba, P. (2010) Trials and tribulations of an African-led research and capacity development programme: The case for EDCTP investments. Tropical Medicine & International Health, 15(4), 489-494.
   Google Scholar
• Mandel, J. S., & Brickley, D. B. (2008) AIDS prevention research in low- and middle-income countries: Generating the evidence upon which local decisions are made. AIDS and Behavior, 12(4 Supplement), S1-S6.
   Google Scholar
• Ginther, D. K.; Schaffer, W. T.; Schnell, J.; Masimore, B.; Liu, F.; Haak, L. L.; & Kington, R. (2011) Race, ethnicity, and NIH research awards. Science, 333(6045), 1015-1019.
   Google Scholar
• Tabak, L. A., & Collins, F. S. (2011) Sociology: Weaving a richer tapestry in biomedical science. Science, 333(6045), 940-941.
   Google Scholar
• Suresh, S. (2011) Moving toward global science. Science, 333(6044), 802.
   Google Scholar
• Shore, D. (2006) Ethical issues in schizophrenia research: A commentary on some current concerns. Schizophrenia Bulletin, 32(1), 26-29.
   Google Scholar
• Dunn, L. B.; Palmer, B. W.; Keehan, M.; Jeste, D. V.; & Appelbaum, P. S. (2006) Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. American Journal of Psychiatry, 163(3), 500-506.
   Google Scholar
• Steinbrook, R. (2009) Controlling conflict of interest—Proposals from the Institute of Medicine. New England Journal of Medicine, 21, 2160-2163.
   Google Scholar
• Lempinen, E. W. (2009) China, U. S. plan projects in S&T ethics education. Science, 324, 1159.
   Google Scholar
• Drain, P. K.; Primack, A.; Hunt, D. D.; Fawzi, W. W.; Holmes, K. K.; & Gardner, P. (2007) Global health in medical education: A call for more training and opportunities. Academic Medicine, 82(3), 226-230.
   Google Scholar
• Archer, N.; Moschovis, P. P.; Le, P. V.; & Farmer, P. (2011) Perspective: Postearthquake Haiti renews the call for global health training in medical education. Academic Medicine, 86(7), 889-891.
   Google Scholar
• Bradford Kerry, V.; Auld, S.; & Farmer, P. (2010) An international service corps for health—An unconventional prescription for diplomacy. New England Journal of Medicine, 363(13), 1199-1201.
   Google Scholar
• LaFraniere, S. (2010) Fighting trend, China is luring scientists home. New York Times, January 6: A1.
   Google Scholar